Jiangsu Aosaikang Pharmaceutical Co., Ltd.

This early-phase study tests a new experimental drug, ASKC202, alone or with another drug (ASK120067), in 150 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink t…